Cargando…

Androgen up-regulates vascular endothelial growth factor expression in prostate cancer cells via an Sp1 binding site

BACKGROUND: Vascular Endothelial Growth Factor (VEGF) is regulated by a number of different factors, but the mechanism(s) behind androgen-mediated regulation of VEGF in prostate cancer are poorly understood. RESULTS: Three novel androgen receptor (AR) binding sites were discovered in the VEGF promot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eisermann, Kurtis, Broderick, Carly J, Bazarov, Anton, Moazam, Mustafa M, Fraizer, Gail C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616929/ https://www.ncbi.nlm.nih.gov/pubmed/23369005 http://dx.doi.org/10.1186/1476-4598-12-7

Ejemplares similares

The Androgen Receptor and VEGF: Mechanisms of Androgen-Regulated Angiogenesis in Prostate Cancer
por: Eisermann, Kurtis, et al.
Publicado: (2017)

Evolutionary conservation of zinc finger transcription factor binding sites in promoters of genes co-expressed with WT1 in prostate cancer
por: Eisermann, Kurtis, et al.
Publicado: (2008)

Poly (A) Binding Protein Cytoplasmic 1 Is a Novel Co-Regulator of the Androgen Receptor
por: Eisermann, Kurtis, et al.
Publicado: (2015)

Androgen receptor gene mutation, rearrangement, polymorphism
por: Eisermann, Kurtis, et al.
Publicado: (2013)

Androgen receptor-binding sites are highly mutated in prostate cancer
por: Morova, Tunç, et al.
Publicado: (2020)

Small Molecule Antagonists of the Nuclear Androgen Receptor for the Treatment of Castration-Resistant Prostate Cancer
por: Johnson, James K., et al.
Publicado: (2016)

The Wilms’ tumor gene (WT1) regulates E-cadherin expression and migration of prostate cancer cells
por: Brett, Adina, et al.
Publicado: (2013)

Membrane androgen binding sites are preferentially expressed in human prostate carcinoma cells
por: Stathopoulos, Efstathios N, et al.
Publicado: (2003)

Putative Prostate Cancer Risk SNP in an Androgen Receptor‐Binding Site of the Melanophilin Gene Illustrates Enrichment of Risk SNPs in Androgen Receptor Target Sites
por: Bu, Huajie, et al.
Publicado: (2015)

The androgen receptor inhibits transcription of GPER1 by preventing Sp1 and Sp3 from binding to the promoters in prostate cancer cells
por: McDermott, Austin, et al.
Publicado: (2022)

The role of androgen receptors in vascular and cell proliferation of the prostate adenocarcinomas
por: Pănuş, Andrei, et al.
Publicado: (2020)

Analysis of gene expression in prostate cancer epithelial and interstitial stromal cells using laser capture microdissection
por: Gregg, Jennifer L, et al.
Publicado: (2010)

Androgen receptor binding sites enabling genetic prediction of mortality due to prostate cancer in cancer-free subjects
por: Ito, Shuji, et al.
Publicado: (2023)

Vascular responses to radiotherapy and androgen-deprivation therapy in experimental prostate cancer
por: Røe, Kathrine, et al.
Publicado: (2012)

Androgen receptor signalling in Vascular Endothelial cells is dispensable for spermatogenesis and male fertility
por: O'Hara, Laura, et al.
Publicado: (2012)

Human SP-D Acts as an Innate Immune Surveillance Molecule Against Androgen-Responsive and Androgen-Resistant Prostate Cancer Cells
por: Thakur, Gargi, et al.
Publicado: (2019)

Effect of cell density on thrombin binding to a specific site on bovine vascular endothelial cells
Publicado: (1981)

Androgen receptor DNA binding and chromatin accessibility profiling in prostate cancer
por: Nevedomskaya, Ekaterina, et al.
Publicado: (2015)

TET2 binds the androgen receptor and loss is associated with prostate cancer
por: Nickerson, ML, et al.
Publicado: (2016)

Targeting Alternative Sites on the Androgen Receptor to Treat Castration-Resistant Prostate Cancer
por: Lallous, Nada, et al.
Publicado: (2013)

Androgens and prostate disease
por: Cooper, Lori A, et al.
Publicado: (2014)

Regulation of Prostate Androgens by Megalin and 25-hydroxyvitamin D Status: Mechanism for High Prostate Androgens in African American Men
por: Garcia, Jason, et al.
Publicado: (2023)

Microarray analysis of androgen-regulated gene expression in testis: the use of the androgen-binding protein (ABP)-transgenic mouse as a model
por: Petrusz, Peter, et al.
Publicado: (2005)

SelexGLM differentiates androgen and glucocorticoid receptor DNA-binding preference over an extended binding site
por: Zhang, Liyang, et al.
Publicado: (2018)

Biological and Clinical Significance of Androgens and Androgen Receptor in Prostate Cancer
por: Koochekpour, Shahriar
Publicado: (2014)

Androgen resistance in prostate cancer
por: Waxman, J, et al.
Publicado: (2008)

Androgens, aging, and prostate health
por: Welén, Karin, et al.
Publicado: (2022)

Recent Discoveries in the Androgen Receptor Pathway in Castration-Resistant Prostate Cancer
por: Obinata, Daisuke, et al.
Publicado: (2020)

Structural studies of neuropilin‐2 reveal a zinc ion binding site remote from the vascular endothelial growth factor binding pocket
por: Tsai, Yi‐Chun Isabella, et al.
Publicado: (2016)

Mithramycin Targets Sp1 and The Androgen Receptor Transcription Level—Potential Therapeutic Role in Advanced Prostate Cancer
por: Wang, Long G., et al.
Publicado: (2006)

Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells
por: Chen, Mengqian, et al.
Publicado: (2010)

Connexin 43 expression is associated with increased malignancy in prostate cancer cell lines and functions to promote migration
por: Zhang, Ao, et al.
Publicado: (2015)

Correction: Connexin 43 expression is associated with increased malignancy in prostate cancer cell lines and functions to promote migration
por: Zhang, Ao, et al.
Publicado: (2023)

Androgens as therapy for androgen receptor-positive castration-resistant prostate cancer
por: Chuu, Chih-Pin, et al.
Publicado: (2011)

Response to Androgens and Androgen Receptor Antagonists in the Presence of Cytokines in Prostate Cancer
por: Culig, Zoran
Publicado: (2021)

Androgen Metabolism and Response in Prostate Cancer Anti-Androgen Therapy Resistance
por: Zhang, Haozhe, et al.
Publicado: (2022)

The Effects of Tetrapeptides Designed to Fit the Androgen Binding Site of ZIP9 on Myogenic and Osteogenic Cells
por: Malviya, Viveka Nand, et al.
Publicado: (2021)

Modulation of neointimal lesion formation by endogenous androgens is independent of vascular androgen receptor
por: Wu, Junxi, et al.
Publicado: (2014)

Associations between Peripheral Thromboembolic Vascular Disease and Androgen Deprivation Therapy in Asian Prostate Cancer Patients
por: Lu, Yu-Chuan, et al.
Publicado: (2019)

Androgen Deprivation Therapy in Patients with Prostate Cancer is Associated with the Risk of Subsequent Alzheimer's Disease but Not with Vascular Dementia
por: Kim, Jong Won, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nglql6me5hsv1gfgf1lmuret9j